Clinical outcomes and prognostic factors of repeated conventional hypofractionated radiotherapy for recurrent intranasal tumors in dogs

Background: Despite an initial favorable response to hypofractionated radiotherapy (RT), intranasal neoplasia has a poor long-term prognosis. Re-irradiation (re-RT) has been shown to result in clinical remission in dogs with recurrent intranasal tumors. Hypofractionated re-RT is indicated in cases...

Full description

Bibliographic Details
Published in:	Open Veterinary Journal
Main Authors:	Hirona Ueno, Yuta Nishiyama, Takuya Maruo, Yohei Fukuda, Takayuki Katayama, Shinichiro Yoda, Kotaro Nishi, Hideki Kayanuma
Format:	Article
Language:	English
Published:	Tripoli University 2025-02-01
Subjects:	dog hypofractionated radiotherapy intranasal tumor recurrence re-irradiation
Online Access:	http://www.ejmanager.com/fulltextpdf.php?mno=226692

Similar Items

Concurrent Boost with Adjuvant Breast Hypofractionated Radiotherapy and Toxicity Assessment
by: Mona M. Sayed, et al.
Published: (2015-01-01)

Re-irradiation for recurrent glioblastoma: a pattern of care analysis
by: Susanne Rogers, et al.
Published: (2024-11-01)

Acute toxicity outcomes in Egyptian early-stage breast cancer: ultra-hypofractionated versus hypofractionated radiotherapy
by: Ahmed Magdy, et al.
Published: (2025-05-01)

Ultra-hypofractionated one-week locoregional radiotherapy for patients with early breast cancer: Acute toxicity results
by: Ivica Ratosa, et al.
Published: (2024-05-01)

Effectiveness of hypofractionated and normofractionated radiotherapy in a triple‐negative breast cancer model
by: Sinja Grosche, et al.
Published: (2022-10-01)

Acute Cardiotoxicity With Concurrent Trastuzumab and Hypofractionated Radiation Therapy in Breast Cancer Patients
by: Mutlay Sayan, et al.
Published: (2019-10-01)

Hypofractionation with simultaneous integrated boost after breast-conserving surgery: Long term results of two phase-II trials
by: Charlotte Pfaffendorf, et al.
Published: (2022-08-01)

Extreme Hypofractionation with SBRT in Localized Prostate Cancer
by: Maria Antonia Gómez-Aparicio, et al.
Published: (2021-08-01)

Efficacy and Toxicity of Hypofractionated Palliative Radiotherapy for Breast Cancer Patients with Skin Invasion
by: Talha Maqsood, et al.
Published: (2023-08-01)

Hypofractionation: The standard for external beam breast irradiation
by: Adrian Murray Brunt, et al.
Published: (2023-06-01)

Hypofractionated Radiotherapy for Hematologic Malignancies during the COVID-19 Pandemic and Beyond
by: Febin Antony, et al.
Published: (2024-01-01)

Efficiency of moderately hypofractionated radiotherapy in NSCLC cell model
by: Marcus Lüdeking, et al.
Published: (2024-04-01)

Hypofractionation and Concomitant Boost in Ductal Carcinoma In Situ (DCIS): Analysis of a Prospective Case Series with Long-Term Follow-Up
by: Domenico Cante, et al.
Published: (2022-06-01)

Hypofractionated partial breast irradiation after breast-conserving surgery for patients with early stage breast cancer in China Mainland: a single-arm prospective trial
by: Xiaomeng Zhang, et al.
Published: (2025-01-01)

Weekly ultra-hypofractionated radiotherapy in localised prostate cancer
by: Nora Sundahl, et al.
Published: (2024-07-01)

Moderate hypofractionation in prostate cancer: experience from Regional Hospital ISSSTE, Morelos
by: Felipe de J. Tallabs-Villafaña, et al.
Published: (2023-01-01)

Acute toxicity patterns and their management after moderate and ultra- hypofractionated radiotherapy for prostate cancer: A prospective cohort study
by: F. Sinzabakira, et al.
Published: (2024-09-01)

Cost Minimization Analysis of Hypofractionated Radiotherapy
by: Hannah L. Yaremko, et al.
Published: (2021-01-01)

Long-Term Results of Postoperative Hypofractionated Accelerated Breast and Lymph Node Radiotherapy (HypoAR) with Hypofractionated Boost
by: Ioannis M. Koukourakis, et al.
Published: (2021-09-01)

Ultra-Hypofractionation for Whole-Breast Irradiation in Early Breast Cancer: Interim Analysis of a Prospective Study
by: Valeria Sigaudi, et al.
Published: (2022-10-01)

Use of hypofractionated radiotherapy regimens after organ-sparing surgery for Stages I–IIA breast cancers
by: Yu. V. Efimkina, et al.
Published: (2014-08-01)

Moderately hypofractionated radiation therapy for breast cancer: A Brazilian cohort study
by: Gabriela S.M. de Siqueira, et al.
Published: (2022-10-01)

MODERATE HYPOFRACTIONATION RADIATION THERAPY IN ESOPHAGEAL CANCER
by: Mahwish Akhter, et al.
Published: (2019-04-01)

Studies of Intra-Fraction Prostate Motion During Stereotactic Irradiation in First Irradiation and Re-Irradiation
by: Alexandre Taillez, et al.
Published: (2021-07-01)

Set-up error and CTV margin in one-week ultra-hypofractionated whole breast irradiation after breast-conserving surgery based on daily CBCT
by: WANG Mengxiao, FAN Wendong, CAO Jingjing, CHEN Jiayi, CAI Gang, CAO Lu
Published: (2025-08-01)

Hypofractionated Palliative Radiotherapy for Relapsed and Refractory High-Risk Neuroblastoma
by: Ellery Koelker-Wolfe, et al.
Published: (2025-02-01)

Hypofractionated versus standard fractionation radiotherapy for merkel cell carcinoma
by: Lorein Gonzalez, et al.
Published: (2024-10-01)

A prospective feasibility study on extreme hypofractionation in adjuvant radiation of breast cancer in a tertiary cancer center in India
by: Sri Sai Tejaswini Muddana, et al.
Published: (2025-07-01)

The Potential of Hypofractionated Radiotherapy: A Revolutionary Treatment for Anorectal Malignant Melanomas
by: Vandana Thakur, et al.
Published: (2025-01-01)

Hypofractionated radiotherapy regimens after organ-sparing surgery for stages I–IIa breast cancer
by: Yu. V. Efimkina, et al.
Published: (2014-08-01)

Normal tissue complications following hypofractionated chest wall radiotherapy in breast cancer patients and their correlation with patient, tumor, and treatment characteristics
by: Mohsin Khan, et al.
Published: (2017-01-01)

Hypofractionated Post-Prostatectomy Radiotherapy in 16 Fractions: A Single-Institution Outcome
by: Pavol Dubinsky, et al.
Published: (2023-07-01)

Carcinoma buccal mucosa treated with definitive hypofractionated accelerated radiotherapy: a retrospective analysis of treatment outcomes
by: Geethu Babu, et al.
Published: (2025-07-01)

Comparison of four-year toxicities and local control of ultra-hypofractionated vs moderate-hypofractionated image guided prostate radiation with HDR brachytherapy boost: A phase I-II single institution trial
by: M.M. Beaudry, et al.
Published: (2023-05-01)

A Prospective Study of High Dose-Rate Brachytherapy or Stereotactic Body Radiotherapy of Intra-Prostatic Recurrence: Toxicity and Long Term Clinical Outcome
by: Una Ryg, et al.
Published: (2022-04-01)

Clinical and pharmacokinetics overview of intranasal administration of fentanyl
by: Samaneh Nakhaee, et al.
Published: (2023-12-01)

Hypofractionated Stereotactic Radiotherapy for the Treatment of Benign Intracranial Meningiomas: Long-Term Safety and Efficacy
by: Eric K. Nguyen, et al.
Published: (2021-09-01)

Combinatorial hypofractionated radiotherapy and pembrolizumab in anaplastic thyroid cancer
by: Janice Ser Huey Tan, et al.
Published: (2024-02-01)

Intranasal dexmedetomidine and intranasal ketamine association allows shorter induction time for pediatric sedation compared to intranasal dexmedetomidine and oral midazolam
by: Francesca Cossovel, et al.
Published: (2022-01-01)

EFFICACY OF HYPOFRACTIONATED ADJUVANT RADIATION THERAPY IN PATIENTS WITH OPERABLE BREAST CANCER
by: G. V. Afonin, et al.
Published: (2018-11-01)